Is this you? Create Your Porfile
Avatar

Tomoyo Oguri

Japanese Foundation for Cancer Research

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Tomoyo Oguri is active.

Explore More

Publication

Featured researches published by Tomoyo Oguri.

Anti-Cancer Drugs | 2017

Efficacy of bevacizumab and erlotinib combination for leptomeningeal carcinomatosis after failure of erlotinib

Ryo Ariyasu; Atsushi Horiike; Junji Koyama; Masafumi Saiki; Tomoaki Sonoda; Yosuke Kawashima; Natsuki Takano; Tomoyo Oguri; Shingo Nishikawa; Satoru Kitazono; Noriko Yanagitani; Fumiyoshi Ohyanagi; Makoto Nishio

In patients with non-small-cell lung cancer harboring an epithelial growth factor receptor (EGFR) active mutation, central nervous system progression after a response to EGFR tyrosine kinase inhibitors is frequent. Central nervous system metastasis, especially leptomeningeal carcinomatosis (LMC), is a serious complication and no standard treatment has been established for LMC. Here, we report two cases in which the addition of bevacizumab to erlotinib enhanced the efficacy against LMC; as a result, radiographic abnormalities decreased markedly and symptoms were well controlled. This combination treatment may be useful to treat LMC in patients with EGFR-positive non-small-cell lung cancer.

Journal of Clinical Oncology | 2017

Monitoring of peripheral lymphocyte and neutrophil counts to predict efficacy of nivolumab (nivo).

Yosuke Kawashima; Shingo Nishikawa; Ryo Ariyasu; Junji Koyama; Masafumi Saiki; Tomoaki Sonoda; Natsuki Takano; Tomoyo Oguri; Satoru Kitazono; Yuichi Tambo; Noriko Yanagitani; Fumiyoshi Ohyanagi; Atsushi Horiike; Takeshi Horai; Makoto Nishio

Annals of Oncology | 2016

A case treated with nivolumab after small cell lung cancer transformation of mutant EGFR non-small cell lung cancer

Shingo Nishikawa; Yuichi Tambo; Hironori Ninomiya; Tomoyo Oguri; Yosuke Kawashima; Natsuki Takano; Satoru Kitazono; Fumiyoshi Ohyanagi; Atsushi Horiike; Noriko Yanagitani; Yuichi Ishikawa; Makoto Nishio

Journal of Clinical Oncology | 2018

The retrospective analysis of nephrotoxicity for cisplatin dose of CRT compared 100mg/m2 to 80mg/m2 for head and neck cancer (HNC) patients.

Tomoyo Oguri; Kenji Nakano; Naoki Fukuda; Kuniki Kawaguchi; Tetsuya Urasaki; Masatoshi Nishizawa; M. Yunokawa; Makiko Ono; Shinichiro Taira; Junichi Tomomatsu; Takashi Toshiyasu; Hiroki Mitani; Shunji Takahashi

Annals of Oncology | 2018

1113PThe retrospective analysis of nephrotoxicity for cisplatin dose of CRT compared 100 mg/m2 to 80 mg/m2 for head and neck cancer (HNC) patients

Tomoyo Oguri; Kenji Nakano; Naoki Fukuda; K Kawaguchi; Tetsuya Urasaki; M Nishizawa; M. Yunokawa; Makiko Ono; Shinichiro Taira; Junichi Tomomatsu; Takashi Toshiyasu; Hiroki Mitani; Shunji Takahashi

Journal of Clinical Oncology | 2017

Preexistence of CT findings with usual interstitial pneumonia (UIP) pattern correlates to radiation pneumonitis (RP) in non-small cell lung cancer (NSCLC) patients receiving chemoradiotherapy (CRT).

Junji Koyama; Satoru Kitazono; Ryo Ariyasu; Masafumi Saiki; Tomoaki Sonoda; Yosuke Kawashima; Natsuki Takano; Tomoyo Oguri; Shingo Nishikawa; Noriko Yanagitani; Atsushi Horiike; Fumiyoshi Ohyanagi; Katsunori Oikado; Takuyo Kozuka; Makoto Nishio

Journal of Clinical Oncology | 2017

The efficacy and toxicity of osimertinib in T790M-positive NSCLC with acquired resistance to EGFR-TKI in clinical practice.

Tomoaki Sonoda; Noriko Yanagitani; Masafumi Saiki; Ryo Ariyasu; Junji Koyama; Natsuki Takano; Yosuke Kawashima; Tomoyo Oguri; Shingo Nishikawa; Satoru Kitazono; Fumiyoshi Ohyanagi; Atsushi Horiike; Makoto Nishio

Journal of Clinical Oncology | 2017

The reasons why re-biopsies were not performed after failure with EGFR-TKI.

Tomoyo Oguri; Atsushi Horiike; Ryo Ariyasu; Junji Koyama; Masafumi Saiki; Tomoaki Sonoda; Natsuki Takano; Shingo Nishikawa; Satoru Kitazono; Noriko Yanagitani; Fumiyoshi Ohyanagi; Makoto Nishio

Journal of Clinical Oncology | 2017

Clinical and radiological features of advanced RET-rearranged lung cancer.

Masafumi Saiki; Fumiyoshi Ohyanagi; Ryo Ariyasu; Junji Koyama; Tomoaki Sonoda; Yosuke Kawashima; Natsuki Takano; Tomoyo Oguri; Shingo Nishikawa; Satoru Kitazono; Noriko Yanagitani; Atsushi Horiike; Hironori Ninomiya; Kengo Takeuchi; Yuichi Ishikawa; Katsunori Oikado; Makoto Nishio

Journal of Clinical Oncology | 2017

Detection of EGFR mutations in NSCLC patients in clinical practice: Comparison between cobas and Scorpion ARMS method.

Natsuki Takano; Satoru Kitazono; Ryo Ariyasu; Junji Koyama; Masafumi Saiki; Tomoaki Sonoda; Yosuke Kawashima; Tomoyo Oguri; Shingo Nishikawa; Noriko Yanagitani; Fumiyoshi Ohyanagi; Atsushi Horiike; Takeshi Horai; Makoto Nishio

Explore More

Collaboration

Dive into the Tomoyo Oguri's collaboration.

Top Co-Authors
Avatar

Atsushi Horiike

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Fumiyoshi Ohyanagi

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Makoto Nishio

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Noriko Yanagitani

Gunma University

View shared research outputs
Top Co-Authors
Avatar

Satoru Kitazono

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Natsuki Takano

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Yosuke Kawashima

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Shingo Nishikawa

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Junji Koyama

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Masafumi Saiki

Japanese Foundation for Cancer Research

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge